Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody fusion proteins with a modified FcRn binding site

Antibody fusion proteins with a modified FcRn binding site

US Patent 8907066 · Granted Dec 9, 2014

Estimated economic value: $45,770,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted TGFβ inhibition2022
Anti-CD19 antibodies with reduced immunogenicity2021
SIRP-α immunoglobulin fusion proteins2021
Methods of use of anti-CD19 antibodies with reduced immunogenicity2018
Targeted TGFβ inhibitors2017
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Methods of treating cancer using interleukin-12p40 variants having improved stab2015
Anti-CD19 antibodies with reduced immunogenicity2015
Expression and export of angiogenesis inhibitors as immunofusins2014
Anti-CD19 antibodies with reduced immunogenicity2014
Engineered anti-alpha V-integrin hybrid antibodies2013
Stabilization of Fc-interferon-beta fusion proteins2013